शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
LAXMIDENTLNSELaxmi Dental Limited· Healthcare Equipment & SuppliesHighNeutral
Announced Tue, 27 May, 2025 · 02:42 IST

Laxmi Dental Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.

LAXMIDENTL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-4.0%Reaction day
₹399.90
prior close
₹391.70
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-4.0% vs market
Medical Equipment & Supplies peers, median of 8sector+2.0%-6.0% vs sector

On the reaction day the stock moved 4.0 pts less than Nifty Microcap 250 and 6.0 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.6
10m
-1.4
15m
-0.8
30m
-1.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-4.0-0.1-4.0+2.0-6.0
Next day
-6.4+0.2-6.6+0.1-6.5
2d
-5.0+0.6-5.6+0.8-5.8
3d
-3.7+0.9-4.6+1.3-5.1
4d
-2.7+1.0-3.7+0.0-2.7
5d
+0.3+0.7-0.4+1.4-1.1
1w
-0.5+1.8-2.2+0.7-1.1
15d
+6.0+1.7+4.3+0.5+5.5
1m
+7.3+3.1+4.2-3.4+10.6
2m
+11.3+1.7+9.6-0.9+12.2
3m
-16.9-1.0-15.9+8.8-25.8
UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 8Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Laxmi Dental Limited has filed its financial results with the NSE for the period ending March 31, 2025. This is a standard regulatory submission required from all listed companies at the close of each quarter and financial year. The announcement itself does not include any specific numbers, financial metrics, or auditor remarks. The full details on revenue, profit, margins, and balance sheet items will be found in the separate results document. Investors will need to look at the detailed results filing to evaluate the company's Q4 FY25 and full-year FY25 performance.

Likely market impact

This is a routine compliance filing with no direct impact on the stock price. Investors should review the detailed financial results document to assess actual revenue, profit, and margin trends before drawing any conclusions.